Diagnosis and management of heart failure: implications of the recent European Society of Cardiology Guidelines for the older patient.
Gillespie
Neil D
ND
Department of Medicine (Ageing & Health), Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. n.d.gillespie@dundee.ac.uk
McMurdo
Marion E T
ME
Struthers
Allan D
AD
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D015897:Comorbidity; D003430:Cross-Sectional Studies; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects; D004232:Diuretics / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D004452:Echocardiography; D005060:Europe / Q000453:epidemiology; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D020097:Natriuretic Peptide, Brain / Q000097:blood; D017410:Practice Guidelines as Topic; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D020097:Natriuretic Peptide, Brain; D004077:Digoxin